Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager

Xvivo Perfusion AB

STO:XVIVO

Watchlist

Dividends

Price: 453 SEK 0.11% Market Closed

Market Cap: 14.3B SEK

Have any thoughts about
Xvivo Perfusion AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 453 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

XVIVO Alert

Xvivo Perfusion AB

453

+0.5 (+0.11%)

52 Week Range	254 539
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Xvivo Perfusion AB

What unique competitive advantages
does Xvivo Perfusion AB hold over its rivals?

What risks and challenges
does Xvivo Perfusion AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Xvivo Perfusion AB.

What unique competitive advantages
does Xvivo Perfusion AB hold over its rivals?

What risks and challenges
does Xvivo Perfusion AB face in the near future?

Summarize the latest earnings call
of Xvivo Perfusion AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Xvivo Perfusion AB.

Provide P/S
for Xvivo Perfusion AB.

Provide P/E
for Xvivo Perfusion AB.

Provide P/OCF
for Xvivo Perfusion AB.

Provide P/FCFE
for Xvivo Perfusion AB.

Provide P/B
for Xvivo Perfusion AB.

Provide EV/S
for Xvivo Perfusion AB.

Provide EV/GP
for Xvivo Perfusion AB.

Provide EV/EBITDA
for Xvivo Perfusion AB.

Provide EV/EBIT
for Xvivo Perfusion AB.

Provide EV/OCF
for Xvivo Perfusion AB.

Provide EV/FCFF
for Xvivo Perfusion AB.

Provide EV/IC
for Xvivo Perfusion AB.

Show me price targets
for Xvivo Perfusion AB made by professional analysts.

What are the Revenue projections
for Xvivo Perfusion AB?

How accurate were the past Revenue estimates
for Xvivo Perfusion AB?

What are the Net Income projections
for Xvivo Perfusion AB?

How accurate were the past Net Income estimates
for Xvivo Perfusion AB?

What are the EPS projections
for Xvivo Perfusion AB?

How accurate were the past EPS estimates
for Xvivo Perfusion AB?

What are the EBIT projections
for Xvivo Perfusion AB?

How accurate were the past EBIT estimates
for Xvivo Perfusion AB?

Compare the revenue forecasts
for Xvivo Perfusion AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Xvivo Perfusion AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Xvivo Perfusion AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Xvivo Perfusion AB compared to its peers.

Compare the P/E ratios
of Xvivo Perfusion AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Xvivo Perfusion AB with its peers.

Analyze the financial leverage
of Xvivo Perfusion AB compared to its main competitors.

Show all profitability ratios
for Xvivo Perfusion AB.

Provide ROE
for Xvivo Perfusion AB.

Provide ROA
for Xvivo Perfusion AB.

Provide ROIC
for Xvivo Perfusion AB.

Provide ROCE
for Xvivo Perfusion AB.

Provide Gross Margin
for Xvivo Perfusion AB.

Provide Operating Margin
for Xvivo Perfusion AB.

Provide Net Margin
for Xvivo Perfusion AB.

Provide FCF Margin
for Xvivo Perfusion AB.

Show all solvency ratios
for Xvivo Perfusion AB.

Provide D/E Ratio
for Xvivo Perfusion AB.

Provide D/A Ratio
for Xvivo Perfusion AB.

Provide Interest Coverage Ratio
for Xvivo Perfusion AB.

Provide Altman Z-Score Ratio
for Xvivo Perfusion AB.

Provide Quick Ratio
for Xvivo Perfusion AB.

Provide Current Ratio
for Xvivo Perfusion AB.

Provide Cash Ratio
for Xvivo Perfusion AB.

What is the historical Revenue growth
over the last 5 years for Xvivo Perfusion AB?

What is the historical Net Income growth
over the last 5 years for Xvivo Perfusion AB?

What is the current Free Cash Flow
of Xvivo Perfusion AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Xvivo Perfusion AB.

XVIVO

Cash Flow Statement

Cash from Financing Activities

Xvivo Perfusion AB
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Xvivo Perfusion AB
Cash from Financing Activities Peer Comparison

Comparables:

OSSD

DOXA

BACTI B

VIMIAN

S2M

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Xvivo Perfusion AB STO:XVIVO	Cash from Financing Activities -kr12.2m	CAGR 3-Years -45%	CAGR 5-Years N/A	CAGR 10-Years N/A
O	OssDsign AB STO:OSSD	Cash from Financing Activities kr135.4m	CAGR 3-Years 60%	CAGR 5-Years 21%	CAGR 10-Years N/A
D	Doxa AB STO:DOXA	Cash from Financing Activities kr686.1m	CAGR 3-Years 374%	CAGR 5-Years N/A	CAGR 10-Years 45%
	Bactiguard Holding AB STO:BACTI B	Cash from Financing Activities -kr11.8m	CAGR 3-Years N/A	CAGR 5-Years -19%	CAGR 10-Years N/A
V	Vimian Group AB STO:VIMIAN	Cash from Financing Activities -€21.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
S	S2Medical AB (publ) STO:S2M	Cash from Financing Activities -kr13.6m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Xvivo Perfusion AB's Cash from Financing Activities?

Cash from Financing Activities
-12.2m SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Cash from Financing Activities amounts to -12.2m SEK.

What is Xvivo Perfusion AB's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 3Y
-45%

The average annual Cash from Financing Activities growth rates for Xvivo Perfusion AB have been -45% over the past three years .

Xvivo Perfusion AB
STO:XVIVO

Xvivo Perfusion AB
Cash from Financing Activities

Xvivo Perfusion AB
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Xvivo Perfusion AB's Cash from Financing Activities?

Cash from Financing Activities
-12.2m SEK

What is Xvivo Perfusion AB's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 3Y
-45%

Company

Help

Tools

Stocks

Xvivo Perfusion AB STO:XVIVO

Xvivo Perfusion AB Cash from Financing Activities

Xvivo Perfusion AB Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Xvivo Perfusion AB's Cash from Financing Activities? Cash from Financing Activities -12.2m SEK

What is Xvivo Perfusion AB's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 3Y -45%

Company

Help

Tools

Stocks

Xvivo Perfusion AB
STO:XVIVO

Xvivo Perfusion AB
Cash from Financing Activities

Xvivo Perfusion AB
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is Xvivo Perfusion AB's Cash from Financing Activities?

Cash from Financing Activities
-12.2m SEK

What is Xvivo Perfusion AB's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 3Y
-45%